help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 18, 2009
Am. J. Respir. Cell Mol. Biol. 2009, doi:10.1165/rcmb.2009-0123OC
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kuhn, A. R
Right arrow Articles by Singer, C. A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhn, A. R
Right arrow Articles by Singer, C. A

Submitted on April 8, 2009
Accepted on June 17, 2009

MicroRNA Expression in Human Airway Smooth Muscle Cells: Role of miR-25 in Regulation of Airway Smooth Muscle Phenotype

Andrew R Kuhn1, Karen Schlauch2, Ronna Lao1, Andrew J Halayko3, William T Gerthoffer4, and Cherie A Singer5*

1 Pharmacology, University of Nevada School of Medicine, Reno, Nevada, United States, 2 Biochemistry, UNR Bioinformatics Core, University of Nevada School of Medicine, Reno, Nevada, United States, 3 Physiology and Section of Respiratory Diseases, University of Manitoba, Winnepeg, Canada, 4 Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, United States, 5 Pharmacology, University of Nevada School of Medicine, MS318, Reno, 89523, United States

* To whom correspondence should be addressed. E-mail: csinger{at}medicine.nevada.edu.

Mechanisms by which differentiated, contractile smooth muscle cells become proliferative and secretory is one way airway smooth muscle (ASM) cells respond to mechanical and environmental stress and contributes to inflammatory responses in the lung that result in airway disease. Regulation by microRNAs (miRNAs) has emerged as an important post-transcriptional mechanism regulating gene expression that may modulate ASM phenotype but little is known about the expression and functions of miRNA in smooth muscle. In the present studies, we use microarrays to determine if miRNAs in human ASM cells are altered by a pro-inflammatory stimulus. In ASM cells exposed to IL-1{beta}, TNF{alpha}, and IFN{gamma}, we found 11 miRNA significantly down-regulated and further verified decreased expression of miR-25, miR-140*, mir-188 and miR-320 by quantitative PCR. Analysis of miR-25 expression indicates that it has a broad role in regulating ASM phenotype by modulating expression of inflammatory mediators such as RANTES, eotaxin and TNF{alpha}; genes involved in extracellular matrix turnover; and contractile proteins, most notably myosin heavy chain. miRNA binding algorithms predict that miR-25 targets Krüppel-like factor 4 (KLF4), a potent inhibitor of smooth muscle specific gene expression and mediator of inflammation. Our study demonstrates that inhibition of miR-25 in cytokine-stimulated ASM cells up-regulates KLF4 expression via a post-transcriptional mechanism. This provides novel evidence that miR-25 targets KLF4 in ASM cells and proposes that miR-25 may be an important mediator of ASM phenotype.


Key words: smooth muscle • gene expression • miRNA • inflammation • remodeling







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2009 American Thoracic Society.
  Red In Translatin